Whitehawk Therapeutics develops antibody drug conjugates for cancer treatment, with its candidates in early clinical trials and based in New Jersey. WHWK reports earnings on Thu, Nov 5, 2026.
Earnings
Earnings calendar →Analyst Ratings & Price Targets
Analyst Ratings →| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Oct 1 | Stifel | Initiated | Buy | |
| Jul 13 | Leerink Partners | Initiated | Buy | |
| Jun 25 | B. Riley Securities | Initiated | Buy | |
| Apr 16 | Citizens | Initiated | Buy |
Seasonality
How WHWK has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2017.
Whale Options Flow
90DNo whale options trades in WHWK in the last 90 days.
AI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether WHWK is in one of them and how their past WHWK trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered WHWK in an article yet. Here's the latest on the wider market.
About Whitehawk Therapeutics
Whitehawk Therapeutics is a drug developer based in Morristown, New Jersey, focused on cancer treatments. It is developing antibody drug conjugates, a type of treatment designed to deliver a cell-killing drug directly to tumor cells. Its product candidates are in early clinical trials for solid tumors such as lung, ovarian and endometrial cancers. The company's intended customers are cancer patients and the medical providers who treat them.
- Headquarters
- Morristown, NJ